Compare DRTS & ESRT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | DRTS | ESRT |
|---|---|---|
| Founded | 2015 | 2011 |
| Country | Israel | United States |
| Employees | 121 | 642 |
| Industry | Medical/Dental Instruments | Real Estate Investment Trusts |
| Sector | Health Care | Real Estate |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.0B | 836.1M |
| IPO Year | N/A | 2012 |
| Metric | DRTS | ESRT |
|---|---|---|
| Price | $13.15 | $4.87 |
| Analyst Decision | Strong Buy | Hold |
| Analyst Count | 3 | 3 |
| Target Price | ★ $8.67 | $6.35 |
| AVG Volume (30 Days) | 553.0K | ★ 1.7M |
| Earning Date | 05-18-2026 | 04-29-2026 |
| Dividend Yield | N/A | ★ 2.49% |
| EPS Growth | ★ N/A | N/A |
| EPS | ★ N/A | N/A |
| Revenue | N/A | ★ $768,270,000.00 |
| Revenue This Year | N/A | $4.26 |
| Revenue Next Year | $699.98 | $1.52 |
| P/E Ratio | ★ N/A | $488.00 |
| Revenue Growth | N/A | ★ 0.05 |
| 52 Week Low | $3.01 | $4.78 |
| 52 Week High | $14.11 | $8.07 |
| Indicator | DRTS | ESRT |
|---|---|---|
| Relative Strength Index (RSI) | 57.08 | 34.64 |
| Support Level | $11.24 | N/A |
| Resistance Level | $14.00 | $5.85 |
| Average True Range (ATR) | 0.80 | 0.21 |
| MACD | -0.02 | -0.08 |
| Stochastic Oscillator | 69.05 | 9.05 |
Alpha Tau Medical Ltd is a clinical-stage oncology therapeutics company focused on harnessing the innate relative biological effectiveness and short range of alpha particles for use as a localized radiation therapy for solid tumors. Its proprietary Alpha DaRT technology is designed to utilize the specific therapeutic properties of alpha particles while aiming to overcome, and even harness for potential benefit, the traditional shortcomings of alpha radiation's limited range. The company has active clinical programs targeting a range of different tumor types, such as head and neck cancer, pancreatic cancer, brain cancer, liver metastases, lung cancer, and prostate cancer. Geographically, it operates in Israel, United States, and Japan with the majority of the revenue generated from Israel.
Empire State Realty Trust Inc is a real estate investment trust (REIT) that owns and operates office, retail, and multifamily properties located in New York City, prominently in Manhattan. Its portfolio includes office and retail space as well as residential units. The company's objective is to maximize cash flow and total returns to its shareholders and to increase the value of the properties. Its reportable segments consist of a real estate segment and an Observatory segment. The majority of revenue is derived from the Real Estate segment, which includes all activities related to the ownership, management, operation, acquisition, redevelopment, repositioning and disposition of its traditional real estate assets.